Our own work recently identified a stromal signature of ovarian cancer metastasis and identified nicotinamide N-methyltransferase (NNMT) as a promising new drug target against cancer-associated fibroblasts (Eckert et al, 2019). This evidence concerns the gene NNMT and cancer.